Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtech industry challenged by inconsistent codes of ethics

This article was originally published in RAJ Devices

Executive Summary

International medtech companies are finding it increasingly difficult to digest the numerous and inconsistent codes of ethics around the world, whether voluntary or imposed on industry through legislation. Furthermore, they are concerned about efforts being taken by individual states in the US to impose, by law, more stringent rules. Karen Finn reports from the 2009 International Medical Device Industry Compliance, Regulatory and Intellectual Property Conference – organised by US medtech industry association AdvaMed – in Rome, Italy, from 25-27 May.

You may also be interested in...



Global medtech alliance approves six new member associations

An emerging alliance of medical technology industry associations representing innovative companies that currently develop and manufacture 85% of the world's medical devices, diagnostics and equipment has approved the membership applications of six more associations, bringing the total number of members to 19.

Global medtech alliance approves six new member associations

An emerging alliance of medical technology industry associations representing innovative companies that currently develop and manufacture 85% of the world's medical devices, diagnostics and equipment has approved the membership applications of six more associations, bringing the total number of members to 19.

US FDA scrutiny of DTC genetic tests continues

The US FDA's devices unit has written to three genetic testing companies warning them that they may be marketing their products and services without clearance by the agency.

UsernamePublicRestriction

Register

OM004967

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel